πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Vertex Pharmaceuticals (Australia) Patents

Full USPTO pharma patent portfolio for Vertex Pharmaceuticals (Australia) β€” grant dates, expiration, and drug cross-links.

Patents
991
Expiring ≀24m
63

Quick answer

Vertex Pharmaceuticals (Australia) has 991 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 63 expire within 24 months β€” use filters for patent-cliff planning.

Page 15 of 21

  1. US 7879891

    Caspase inhibitor prodrugs

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7879834

    Spiroindoline modulators of muscarinic receptors

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7880008

    Heterocycles useful as modulators of ion channels

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7875712

    Caspase inhibitors and uses thereof

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7872129

    Compositions useful as inhibitors of GSK-3

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7872031

    c-MET protein kinase inhibitors

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7863449

    Modulators of muscarinic receptors

    Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7863282

    Compositions useful as inhibitors of protein kinases

    Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7858635

    Spiro compounds as modulators of muscarinic receptors

    Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7858786

    Pyrimidines and pyrazines useful as modulators of ion channels

    Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7858790

    Modulators of muscarinic receptors

    Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7855220

    Bicyclic derivatives as modulators of voltage gated ion channels

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7855214

    Fused cyclic systems useful as inhibitors of TEC family protein kinases

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7851495

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7846954

    Heterocyclic derivatives as modulators of ion channels

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7846951

    Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7842819

    Derivatives for modulation of ion channels

    Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7842686

    CGRP receptor antagonists

    Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7838517

    Compounds useful as protein kinase inhibitors

    Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7834000

    CGRP receptor antagonists

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7834200

    Processes and intermediates

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7829561

    Caspase inhibitors and uses thereof

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7829723

    Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7825136

    Potentiators of antibacterial activity

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7820671

    Peptidomimetic protease inhibitors

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7820817

    Modulators of muscarinic receptors

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7820685

    Aminopyrimidines useful as kinase inhibitors

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7816529

    Pyrimidines useful as modulators of voltage-gated ion channels

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7807659

    Caspase inhibitors and uses thereof

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7799822

    Phenyl sulfonamides as modulators of ion channels

    Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7795259

    Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7790713

    Inhibitors of interleukin-1Ξ² converting enzyme

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7786107

    Modulators of muscarinic receptors

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7786141

    Dihydrospiroindene modulators of muscarinic receptors

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7786130

    Pyridones useful as inhibitors of kinases

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7786308

    Muscarinic modulators

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7786120

    Pyridones useful as inhibitors of kinases

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7786137

    Bicyclic derivatives as modulators of ion channels

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7777069

    Prodrugs of carbamate inhibitors of IMPDH

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7776887

    Processes and intermediates

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7776905

    Modulators of ATP-binding cassette transporters

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7772366

    Inhibitors of interleukin-1Ξ² converting enzyme

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7767816

    Azaindoles useful as inhibitors of janus kinases

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7767672

    Aminopyrimidines useful as kinase inhibitors

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7767680

    Ion channel modulators and methods of use

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7763629

    Tetrahydropteridines useful as inhibitors of protein kinases

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7754739

    Modulators of CFTR

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7745444

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Vertex Pharmaceuticals (Australia) have?

991 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Vertex Pharmaceuticals (Australia) patents expire?

63 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.